Abstract
The current state of research into new methods of male contraception is reviewed, with special emphasis on the efforts of the WHO Special Programme of Research, Development and Research Training in Human Reproduction. The article concentrates mainly on the development of orally administered or injectable substances capable of either (a) interfering with the hormonal control of testicular function, (b) disrupting spermatogenesis by direct influence on testis function, or (c) interfering with the fertilizing ability of the sperm and their transport. It is concluded that, despite the numerous areas of research currently being pursued, the availability of a new male contraceptive remains several years away.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Boyer J. L., Preisig R., Zbinden G., de Kretser D. M., Wang C., Paulsen C. A. Guidelines for assessment of potential hepatotoxic effects of synthetic androgens, anabolic agents and progestagens in their use in males as antifertility agents. Contraception. 1976 Apr;13(4):461–468. doi: 10.1016/s0010-7824(76)80031-5. [DOI] [PubMed] [Google Scholar]
- Bremner W. J., de Kretser D. M. The prospects for new, reversible male contraceptives. N Engl J Med. 1976 Nov 11;295(20):1111–1117. doi: 10.1056/NEJM197611112952005. [DOI] [PubMed] [Google Scholar]
- Ewing L. L., Desjardins C., Irby D. C., Robaire B. Synergistic interaction of testosterone and oestradiol inhibits spermatogenesis in rats. Nature. 1977 Sep 29;269(5627):409–411. doi: 10.1038/269409a0. [DOI] [PubMed] [Google Scholar]
- Lubell I., Frischer R. The current status of male and female sterilization procedures. Proc R Soc Lond B Biol Sci. 1976 Dec 10;195(1118):93–114. doi: 10.1098/rspb.1976.0101. [DOI] [PubMed] [Google Scholar]